Back | Next |
home / stock / ptla / ptla message board
Subject | By | Source | When |
---|---|---|---|
Feb 28 coming up! | H2R | investorshub | 02/23/2019 9:41:00 PM |
SoS on Andexxa ANNEX4-A Study: | H2R | investorshub | 02/13/2019 8:52:09 PM |
Positive Hemostasis in 82 Percent of Evaluable Patients | H2R | investorshub | 02/07/2019 9:09:30 PM |
Hi NOLA70124, | H2R | investorshub | 01/02/2019 11:14:59 PM |
H2R - There were ~17M shares short as | NOLA70124 | investorshub | 12/31/2018 9:35:08 PM |
Up %14 on an above average 2.5M shares | H2R | investorshub | 12/31/2018 9:05:14 PM |
$PTLA will target a large number of hospitals | H2R | investorshub | 12/31/2018 9:00:40 PM |
"PAS" APPROVED ! | H2R | investorshub | 12/31/2018 8:44:17 PM |
Trading halt on pending news... | H2R | investorshub | 12/31/2018 7:51:59 PM |
Today is the PDUFA date... Wondering how it | H2R | investorshub | 12/31/2018 7:48:44 PM |
$PTLA getting ready for the PDUFA - December | H2R | investorshub | 12/19/2018 8:29:39 PM |
AMAG acquires Perosphere Pharmaceuticalsowner of FXa antidote in development: | DewDiligence | investorshub | 12/13/2018 1:13:19 PM |
PR from $PTLA: | H2R | investorshub | 12/12/2018 6:54:21 PM |
Well, CHMP chickened out. No pop, but | heyyou2 | investorshub | 12/12/2018 2:46:14 AM |
Interesting comment on SA's | H2R | investorshub | 12/04/2018 3:46:35 PM |
I would not be surprised if there is | Valsartan160 | investorshub | 11/17/2018 8:25:59 AM |
A couple of notes from the CC: | H2R | investorshub | 11/08/2018 5:10:24 PM |
From the PR | H2R | investorshub | 11/08/2018 2:59:29 AM |
was this a key day? | Valsartan160 | investorshub | 10/31/2018 4:21:49 AM |
Cerdulatinib Orphan Drug Designation | H2R | investorshub | 09/25/2018 9:53:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Portola Pharmaceuticals Inc. Company Name:
PTLA Stock Symbol:
NASDAQ Market:
Portola Pharmaceuticals Inc. Website:
SOUTH SAN FRANCISCO, Calif. , May 18, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of stockholders, employees and othe...
SOUTH SAN FRANCISCO, Calif. , May 14, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) has proposed extending the New Technology Add-on Payment (NTAP) for Andexxa ® [coagula...
SOUTH SAN FRANCISCO, Calif. , May 11, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today reported financial results for the three months ended March 31, 2020, and provided a corporate update, including the Company's actions to continue to su...